Form: POSASR

Post-effective Amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR

February 28, 2022

EXHIBIT 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

Sutro Biopharma, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

    Security
Type
  Security
Class Title
  Fee
Calculation
or Carry
Forward
Rule
  Amount
Registered(1)(2)
    Proposed
Maximum
Offering

Price Per
Unit (3)
    Maximum
Aggregate
Offering
Price
    Fee Rate     Amount of
Registration
Fee
    Carry
Forward
Form
Type
    Carry
Forward
File Number
    Carry
Forward
Initial
Effective
Date
    Filing Fee
Previously
Paid in
Connection
with Unsold
Securities
to be
Carried
Forward
 

Newly Registered Securities

 
   

Primary Offering of Securities:

                                                     

Fees to Be Paid

  Equity   Common Stock, $0.0001 par
value per share
  475(r)   $ —       $ —       $ —         —     $ —          

Fees to Be Paid

  Equity   Preferred Stock, $0.0001 par
value per share
  475(r)     —         —         —         —         —            

Fees to Be Paid

  Debt   Debt Securities   475(r)     —         —         —         —         —            

Fees to Be Paid

  Equity   Warrants   475(r)     —         —         —         —         —            

Fees to Be

Paid

  Equity   Units   475(r)     —         —         —         —         —            

Fees to Be

Paid

  Unallocated
(Universal)
Shelf
    457(o)   $ 250,000,000       N/A     $ 250,000,000       0.0000927     $ 23,175          
    Primary Offering of Common Stock:               —       —                                  

Fees to Be Paid

  Equity   Common Stock, par value
$0.0001 per share
  457(o)   $ 100,000,000  (4)      N/A     $ 100,000,000       0.0000927     $ 9,270          

Fees to be Paid

 

Total Registration Fee:

      N/A     $ 350,000,000       0.0000927     $ 32,445          

Carry Forward Securities

 

Carry Forward Securities

  Equity   Common Stock, par value
$0.0001 per share
  457(b)   $ 100,000,000  (4)      N/A     $ 100,000,000           424 (b)(5)      333-255014      
April 2,
2021
 
 
  $ 10,910  
 

Total Offering Amounts

 

    $ 350,000,000       $ 32,445 (4)         
 

Total Fees Previously Paid

 

          —            
 

Total Fee Offsets

 

        $ 10,910          
 

Net Fee Due

 

        $ 21,535          


(1)

There is being registered hereunder an indeterminate number of shares of (a) common stock, (b) preferred stock, (c) debt securities, (d) warrants to purchase common stock, preferred stock or debt securities of the Registrant, (e) subscription rights to purchase common stock, preferred stock or debt securities of the Registrant, and (f) units, consisting of some or all of these securities in any combination, as may be sold from time to time by the Registrant. Any securities registered hereunder may be sold separately or as units with other securities registered hereunder. There is also being registered hereunder an indeterminate number of shares of common stock, preferred stock and debt securities as shall be issuable upon conversion, exchange or exercise of any securities that provide for such issuance. In no event will the aggregate offering price of all types of securities issued by the Registrant pursuant to this registration statement exceed $350,000,000.

(2)

Pursuant to Rule 416(a), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or similar transaction.

(3)

The proposed maximum offering price per share and proposed maximum aggregate offering price for each type of security will be determined from time to time by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder.

(4)

Calculated pursuant to Rule 457(o) under the Securities Act of 1933, as amended. Includes $10,910 previously paid by the Registrant in connection with the registration of $100,000,000 of shares of common stock previously registered pursuant to this Registration Statement, none of which were sold as of the date hereof.

(5)

The securities registered pursuant to this Registration Statement include unsold securities previously registered by the Registrant on this registration statement for the offer and sale of up to $100,000,000 in shares of the Registrant’s common stock (the “Unsold Shelf Securities”), all of which remains unsold as the date of filing of this Post-Effective Amendment No. 1 to this Registration Statement. Pursuant to Rule 457(b) under the Securities Act, the filing fee of $10,910 relating to the Unsold Shelf Securities, will continue to be applied to the Unsold Shelf Securities registered pursuant to this Registration Statement.

Table 2: Fee Offset Claims and Sources

 

       

Registrant or
Filer Name

  Form
or
Filing
Type
    File
Number
    Initial Filing
Date
    Filing Date     Fee
Offset
Claimed
    Security
Type
Associated
with Fee
Offset
Claimed
    Security Title Associated with Fee Offset
Claimed
    Unsold
Securities
Associated
with Fee
Offset
Claimed
    Unsold
Aggregate
Offering
Amount
Associated
with Fee
Offset Claimed
    Fee
Paid
with
Fee
Offset
Source
 

Rule 457(b) and 0-11(a)(2)

 

Fee Offset Claims

 

  

      —         —         —           —              

Fee Offset Sources

    Sutro Biopharma, Inc.     S-3ASR       333-255014       April 2, 2021       April 2, 2021       $10,910       Equity      
Common Stock, par value $0.0001
per
 
 
    N/A     $ 100,000,000     $ 10,910  

Rule 457 (p)

 

Fee Offset

    —       —         —         —           —         —         —         —         —      

Claims

    —       —         —           —                   —